Table 4.

Baseline Characteristics of Patients Before and After PSM

	Before PSM			After PSM
Characteristics	TACE+MWA (n=91)	TACE Alone (n=140)	P	TACE-MWA (n=73)	TACE Alone (n=73)	P
Sex			0.004			1.000
Male	74	131		67	67
Female	17	9		6	6
Age			0.090			0.098
≤55 years	39	76		31	41
>55 years	52	64		42	32
Etiologies of cirrhosis			0.483			0.966
None	8	19		7	5
HBV	77	111		62	63
HCV	3	4		2	2
Alcohol	2	1		1	1
Cryptogenic	1	5		1	2
Platelet count			0.534			0.719
≤50 ×109	3	8		3	5
>50 ×109	88	132		70	68
Albumin			0.298			0.715
≤35 g/L	21	41		20	22
>35 g/L	70	99		53	51
Total bilirubin			0.196			0.730
≤17.1 umol/L	61	82		48	46
>17.1 umol/L	30	58		25	27
AFP level			0.026			0.861
≤400 ng/mL	64	78		48	49
>400 ng/mL	27	62		25	24
Tumor distribution			0.299			0.385
Unilobar	62	86		45	50
Bilobar	29	54		28	23
Size of the largest tumor			<0.001			0.068
≤50 mm	33	16		26	16
>50 mm	58	124		47	57
Number of tumors			0.224			0.320
Single	40	73		31	37
Multiple	51	67		42	36

Abbreviations: PSM, propensity score matching; SD, standard deviation; IQR, interquartile range; AFP, alpha fetoprotein; INR, international normalized ratio.